Mild periorbital edema has been noted as a common side effect in Phase I and II trials of this drug for the treatment of patients with chronic myelogenous leukemia and gastrointestinal stromal tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback